HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kathlynn C Brown Selected Research

Peptide Library

3/2014Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.
1/2010Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.
6/2007A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancer.
4/2006Isolation of multiple cell-binding ligands from different phage displayed-peptide libraries.
4/2006Novel ligands for cancer diagnosis: selection of peptide ligands for identification and isolation of B-cell lymphomas.
12/2004Cell-specific delivery of a chemotherapeutic to lung cancer cells.
12/2003Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kathlynn C Brown Research Topics

Disease

16Neoplasms (Cancer)
06/2015 - 12/2003
6Lung Neoplasms (Lung Cancer)
01/2013 - 12/2004
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 06/2007
3Carcinoma (Carcinomatosis)
09/2011 - 04/2006
1Measles
06/2015
1Adenocarcinoma
05/2009
1Brain Neoplasms (Brain Tumor)
05/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2009
1Neoplasm Metastasis (Metastasis)
05/2009
1Adenocarcinoma of Lung
06/2007
1Lymphoma (Lymphomas)
04/2006
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2006
1Type 2 Diabetes Mellitus (MODY)
07/2005
1Mycoplasma Infections
07/2005
1Cardiovascular Diseases (Cardiovascular Disease)
09/2004

Drug/Important Bio-Agent (IBA)

17Peptides (Polypeptides)IBA
06/2015 - 12/2003
8LigandsIBA
10/2014 - 12/2003
7Peptide LibraryIBA
03/2014 - 12/2003
5Pharmaceutical PreparationsIBA
10/2014 - 12/2003
4Biomarkers (Surrogate Marker)IBA
01/2014 - 06/2007
4IntegrinsIBA
01/2014 - 06/2007
4Indicators and Reagents (Reagents)IBA
06/2007 - 12/2003
2Liposomes (Liposome)IBA
06/2015 - 01/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
02/2010 - 09/2008
2ferric oxide (iron oxide)IBA
02/2010 - 01/2009
2integrin alphavbeta6IBA
05/2009 - 06/2007
1Histocompatibility Antigens Class IIBA
06/2015
1AntigensIBA
06/2015
1HLA Antigens (Human Leukocyte Antigens)IBA
06/2015
1ClathrinIBA
10/2014
1Chlorpromazine (Thorazine)FDA Link
10/2014
1liposomal doxorubicin (Doxil)FDA Link
01/2013
1Paclitaxel (Taxol)FDA LinkGeneric
09/2011
1MicellesIBA
02/2010
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
05/2009
1VimentinIBA
05/2009
1Cadherins (E-Cadherin)IBA
05/2009
1ferric ferrocyanide (Prussian blue)FDA Link
01/2009
1Polyglutamic Acid (Polyglutamate)IBA
09/2008
1Biological ProductsIBA
04/2006
1AntibodiesIBA
04/2006
1Glucose (Dextrose)FDA LinkGeneric
07/2005
1Tryptophan (L-Tryptophan)FDA Link
03/2004
1Ammonium Chloride (Sal Ammoniac)FDA Link
03/2004
12,2'-Dipyridyl (2,2 Bipyridine)IBA
03/2004
1RutheniumIBA
03/2004

Therapy/Procedure

6Therapeutics
06/2015 - 09/2004
1Immunotherapy
06/2015
1Chemoprevention
05/2009